"Novartis Poland" Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers

Secondary Activities: Newspaper, Periodical, Book, and Directory Publishers | Data Processing, Hosting, and Related Services | Research and Development in the Physical, Engineering, and Life Sciences | Advertising Agencies | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services | Management of Companies and Enterprises | Convention and Trade Show Organizers | All Other Miscellaneous Schools and Instruction

Full name: "Novartis Poland" Sp. z o.o.

Profile Updated: January 03, 2026

Novartis Poland Sp. o.o. markets pharmaceuticals. The company was incorporated in 1992 and is based in Warsaw, Poland. Novartis Poland Sp. o.o. operates as a subsidiary of Novartis AG.

Headquarters
Ul. Marynarska 15
Warsaw; Mazowieckie; Postal Code: 02-674

Contact Details: Purchase the "Novartis Poland" Sp. z o.o. report to view the information.

Website: http://www.novartis.pl

Basic Information

Total Employees:

Purchase the "Novartis Poland" Sp. z o.o. report to view the information.

Registered Capital:

Purchase the "Novartis Poland" Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the "Novartis Poland" Sp. z o.o. report to view the information.

Incorporation Date:

October 31, 2001

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after "Novartis Poland" Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

289.92%▲

Total operating revenue

287.23%▲

Operating Profit/Loss (EBIT)

292.49%▲

EBITDA

244.1%▲

Net Profit/Loss for the Period

155.26%▲

Total Assets

263.39%▲

Total Equity

26.25%▲

Operating Profit Margin (ROS)

0.03%▲

Net Profit Margin

-2.3%▼

Return on Equity (ROE)

10.51%▲

Quick Ratio

-1.42%▼

Similar companies